Illirem at 00:37, 26 January 2026

2026-01-26T00:37:24Z

← Older revision		Revision as of 20:37, 25 January 2026
Line 110:		Line 110:
	Dosimetry or biokinetic models:<br>		Dosimetry or biokinetic models:<br>

	[[Category:Isotopes]]		[[Category:Isotopes\|131]]

Illirem: Created page with "

Iodine-131

=1. Isotope Basics= Isotope name:
Symbol / mass number:
Decay mode(s):
Decay products:[''include limited discussions on daughter hazards or link out to them'']
Physical half-life:
Biological half-life:[''include details if the known biological half life is compound specific'']
Use Cases:[''include brief discussion or link out to applicable scope of practice page'']
=2. Hazard Characterization= ==Radiological Hazards== Type..."

2026-01-26T00:34:26Z

Created page with "<h1>Iodine-131</h1> =1. Isotope Basics= Isotope name: Symbol / mass number: Decay mode(s): Decay products:[''include limited discussions on daughter hazards or link out to them''] Physical half-life: Biological half-life:[''include details if the known biological half life is compound specific''] Use Cases:[''include brief discussion or link out to applicable scope of practice page''] =2. Hazard Characterization= ==Radiological Hazards== Type..."

New page

<h1>Iodine-131</h1>

=1. Isotope Basics=
Isotope name: 
Symbol / mass number: 
Decay mode(s): 
Decay products:[''include limited discussions on daughter hazards or link out to them''] 
Physical half-life: 
Biological half-life:[''include details if the known biological half life is compound specific''] 
Use Cases:[''include brief discussion or link out to applicable scope of practice page''] 
=2. Hazard Characterization=
==Radiological Hazards==
Type of radiation emitted: 
Radiation energy(ies): 
External exposure risk: [''low / moderate / high''] 
Internal exposure risk: [''inhalation, ingestion, absorption''] 
Critical organs / tissues: 
Committed dose concerns: 
==Non-radiological Hazards==
Chemical toxicity: 
Volatility / flammability: 
Corrosiveness: 
Biological activity: [''e.g., radiopharmaceuticals''] 
=3. Exposure Pathways=
External exposure: 
Inhalation: 
Ingestion: 
Skin contamination / absorption: 
Injection / wounds: 
=4. Regulatory & Administrative Controls=
Applicable regulations / licenses: 
Authorized users required: 
Activity limits per user / room: 
Training requirements: 
Posting and labeling requirements: 
Record-keeping requirements: 
=5. Detection & Monitoring=
==Area monitoring ==
Recommended survey instrument(s): 
Detection efficiency for this isotope: 
Typical background levels: 
==Personal monitoring: ==
Dosimetry: 
Bioassay requirements: 
Monitoring frequency: 
==Contamination monitoring==
Direct survey vs wipe tests: 
Detection limits and action levels: 
=6. ALARA=
==Time==
==Distance==
Use of remote handling tools:[''tongs, syringe shields, etc.''] 
Minimum distance precautions: 
==Shielding==
Primary radiation to shield: 
Recommended shielding material(s): 
Typical thicknesses: 
Bremsstrahlung considerations: 
Shielding for storage vs handling: 
=7. Handling & Work Practices=
Designated work areas: 
Containment:[''fume hood, glove box, hot cell''] 
Personal protective equipment: 
:Lab coat: 
:Gloves:[''type and change frequency''] 
:Eye / face protection: 
Labeling during use: 
=8. Storage=
Shielded storage container description: 
Secondary containment: 
Security requirements: 
Labeling:[''isotope, activity, date''] 
Ventilation requirements:[''if volatile''] 
=9. Transport=
Approved containers: 
Shielding during transport: 
Labeling and documentation: 
Spill prevention measures: 
=10. Waste Management=
Waste type: 
Segregation requirements: 
Shielding of waste containers: 
Decay-in-storage criteria: 
Disposal route and documentation: 
=11. Decontamination Procedures=
Approved cleaning agents: 
Surface decontamination methods: 
Verification of decontamination: 
Documentation requirements: 
=12. Emergency Procedures=
Spills: 
Personnel contamination: 
:Skin contamination 
:Eye exposure 
:Internal uptake 
Exposure incidents: 
:Dose assessment process 
:Medical follow-up 
:Reporting requirements 
=13. Special Considerations=
Volatility:[''e.g., iodine, tritium''] 
High-energy gamma emitters: 
Short half-life operational challenges: 
Daughter product buildup: 
Activation products: 
=14. References & Supporting Documents=
Safety data sheets: 
Regulatory guidance documents: 
Institutional SOPs: 
Dosimetry or biokinetic models: 

[[Category:Isotopes]]

Iodine-131 - Revision history

Illirem at 00:37, 26 January 2026

Illirem: Created page with "

Iodine-131